Upadacitinib in children under 12 years with dupilumab-refractory severe atopic dermatitis: a real-world case series. Vidal Gonzalez A, Lopez Alcazar S, Escudero Tornero R, Vergara Barria FA, et al. Clin Exp Dermatol 2026 Mar 26:llag143. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Vidal Gonzalez A, Lopez Alcazar S, Escudero Tornero R, Vergara Barria FA, et al. Upadacitinib in children under 12 years with dupilumab-refractory severe atopic dermatitis: a real-world case series. Clin Exp Dermatol 2026 Mar 26:llag143. doi: 10.1093.
PMID: 41885167